New location technology will help get emergency responders closer to 911 callers if they are unable to describe their location. Photo courtesy of AT&T

“911, what’s your location?”

It’s a phrase we’ve heard hundreds of times on TV shows and movies. In real life though, have you ever considered the possibility that this question — one that can mean the difference between life and death — may be hard for the caller to answer? In an emergency, you may not be able to speak. If you’re in a car accident, you may not know where you are. In a disaster, your surroundings may be confusing.

That’s where a new location-based routing feature we call “Locate Before Route” comes in. This summer, AT&T, in collaboration with Intrado, rolled out a first-of-its-kind 911 upgrade across the country that will make it easier for emergency personnel to find and send help to wireless callers.

Roughly 80 percent of 911 calls today are made from cell phones. Before location-based routing, a call would ping a cell phone tower and connect to the dispatch center closest to that tower. But here’s the thing: that cell tower could be up to 10 miles away. Imagine needing help in Deer Park but the dispatcher thinking you may be in Baytown. You could even be in a different county, making it difficult for dispatchers to pinpoint exactly where the call is calling from.

Here’s how it works:

Instead of pinging the closest cell tower, the GPS in your phone connects with the closest 911 dispatch center, meaning emergency operators can locate you within about 55 yards of your position. That’s about half a football field.

This kind of accuracy means public safety can respond faster, especially in situations when a 911 wireless caller doesn’t know or can’t disclose their location.

AT&T is the first wireless carrier to launch location-based routing for all 911 call centers nationwide, whether they’re operating on older technology or NextGen 911. The best part: AT&T customers across the country automatically have access to this service – no action is necessary.

AT&T’s commitment to public safety is longstanding. Following the events of September 11th, we worked to create FirstNet, – the only nationwide communications platform dedicated to public safety and first responders. With nationwide location-based 911 call routing, we are providing our customers with the quickest, most accurate way to call emergency personnel for help when it’s most needed.

------

Luis Silva is vice president and general manager at AT&T.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

European spacecraft developer expands to Houston with U.S. business, new lab

houston hq

European aerospace manufacturer The Exploration Company has established its first U.S. entity and named Space City as its headquarters.

The company announced earlier this month that it has launched TEC Federal to support U.S. government customers and agencies, and to scale The Exploration Company's engineering operations in the country.

Mark Kirasich serves as president of TEC Federal. Kirasich most recently served as the senior director of human spaceflight at Blue Origin after a nearly 40-year career at NASA.

The Exploration Company is developing the reusable Nyx space vehicle. Nyx is designed to take off from any heavy launcher in the world. It will then dock at space stations, retrieve up to 3,000 kilograms of cargo, splash down and return the cargo to Earth. The company aims to make Nyx fully reusable for up to 10 missions, making it a more affordable and sustainable option for aerospace missions.

The Exploration Company completed a successful drop test of the spacecraft in May in the Mojave Desert. The company says Nyx is slated to perform its first flight demonstration in 2028.

In addition to launching the Houston business, The Exploration Company also opened its new Rapid Innovation Lab near Houston's NASA Johnson Space Center on Space Park Drive.

The Exploration Company opened its Rapid Innovation Lab earlier this month. Photo via LinkedIn

The Rapid Innovation Lab features a full-scale mockup of the future Nyx crew capsule as well as ongoing development and testing of the Nyx cargo capsule, according to the company.

The Exploration Company says the new lab will allow its engineers, designers, and operators to prototype and test crew interfaces. It will also support partnerships with NASA personnel and astronauts.

“Houston gives us direct access to the people and expertise that have built and operated human spaceflight systems for decades. We’re excited to invest and expand around that— engineers, operators, and astronauts working together and moving quickly towards building a crew capsule.” Hélène Huby, founder and CEO of The Exploration Company, said in a blog post.

According to The Houston Chronicle, The Exploration Company has about 30 employees in the Houston area.

The company was founded in 2021 by Huby, a French rocket scientist, and has raised more than $350 million in venture capital. It operates out of Germany, France, Luxembourg, Spain and Italy, with offices in the U.S. and the United Arab Emirates. It is also developing a reusable, high-thrust rocket engine known as Storm.

UH lands $4M NIH grant to study early signs of autoimmune disease

NIH funding

The University of Houston recently received a $4 million National Institutes of Health grant to support a 10-year longitudinal study to identify the earliest biological markers of autoimmune disease.

Led by Chandra Mohan, the Hugh Roy and Lillie Cranz Cullen Endowed Professor of Biomedical Engineering, the study aims to examine what causes Systemic Autoimmune Rheumatic Diseases (SARDs) and to identify targets for future treatments. The study will be carried out in collaboration with Dr. Karen Costenbader at Harvard Medical School, Boston.

SARDs include conditions like rheumatoid arthritis, systemic lupus erythematosus, Sjögren’s syndrome and systemic sclerosis—all are considered chronic diseases currently without a cure. Autoimmune diseases affect over 30 million people globally, according to UH.

SARDs occur when the body’s immune system attacks healthy, non-threatening tissues and organs. According to UH, in these diseases, the body often attacks nuclear antigens, creating anti-nuclear autoantibodies, which can be early detection signs for SARDs in more than 50 percent of patients, Mohan says.

Researchers will study blood samples and environmental exposure over the 10 years to better understand anti-nuclear autoantibodies.

“Collectively, these studies will help identify the genetic, environmental and cellular factors that are operative at the two steps of SARD development, namely the emergence of anti-nuclear autoantibodies and disease onset,” Mohan said in a news release. “ More importantly, these studies will highlight functional molecular pathways and mechanisms that may be operative at each step."

Mohan predicts that looking at SARDs’ shared characteristics, rather than each disease individually, could help identify more treatment methods.

“Individual SARDs have been examined in silos without an attempt to discern shared underlying features at the molecular level,” he added in the release. “Current understanding of the initial (and likely shared) origins of SARDs is only rudimentary but urgently needed to develop means for prevention and treatment.”

Earlier this year, UH also received an $11 million NIH grant to conduct a first-of-its-kind study of early language development in children ages 18 to 24 months. Read more here.